[1]Parekh BS, McDougal JS. Application of laboratory methods for estimation of HIV-1 incidence[J].Indian J Med Res,2005,121(4):510-518. [2]Weinstock H, Dale M, Gwinn M,et al. HIV seroincidence among patients at clinics for sexually transmitted diseases in nine cities in the United States[J]. J Acquir Immune Defic Syndr,2002,29(5):478-483. [3]Rawal BD, Degula A, Lebedeva L,et al. Development of a new less-sensitive enzyme immunoassay for detection of early HIV-1 infection[J]. J Acquir Immune Defic Syndr,2003,33(3):349-355. [4]Young CL, Hu DJ, Byers R, et al.Evaluation of a sensitive/less sensitive testing algorithm using the bioMérieux Vironostika-LS assay for detecting recent HIV-1 subtype B' or E infection in Thailand[J]. AIDS Res Hum Retroviruses,2003,19(6):481-486. [5]Parekh BS, Kennedy MS, Dobbs T, et al. Quantitative detection of increasing HIV type 1 antibodies after seroconversion : a simple assay for detecting recent HIV infection and estimating incidence[J]. AIDS Res Hum Retroviruses,2002,18(4):295-307. [6]McDougal JS, Parekh BS, Peterson ML, et al. Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay[J]. AIDS Res Hum Retroviruses,2006,22(10):945-952. [7]Karita E, Price M, Hunter E, et al. Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa[J]. AIDS,2007,21(4):403-408. [8]Guy R, Gold J, Calleja JM, et al. Accuracy of serological assays for detection of recent infection with HIV and estimation of population incidence: a systematic review[J]. Lancet Infect Dis,2009,9(12):747-759. [9]Parekh BS, Hanson DL, Hargrove J,et al. Determination of mean recency period for estimation of HIV type 1 Incidence with the BED-capture EIA in persons infected with diverse subtypes[J]. AIDS Res Hum Retroviruses,2011,27(3):265-273. [10]Duong YT, Qiu M, De AK, et al. Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies[J].PLoS One,2012,7(3):e33328. [11]Welte A, McWalter TA, Brnighausen T. A Simplified Formula for Inferring HIV Incidence from Cross-Sectional Surveys Using a Test for Recent Infection[J]. AIDS Res Hum Retroviruses,2009,25(1):125-126. [12]Brookmeyer R. Crorrespondence[J]. AIDS,2009,23(15):2061-2068. [13]Brookmeyer R.On the statistical accuracy of biomarker assays for HIV incidence[J]. J Acquir Immune Defic Syndr,2010,54(4):406-414. [14]Marinda ET, Hargrove J, Preiser W, et al. Significantly diminished long-term specificity of the BED capture enzyme immunoassay among patients with HIV-1 with very low CD 4 counts and those on antiretroviral therapy[J]. J Acquir Immune Defic Syndr,2010,53(4):496-499. [15]Kim AA, McDougal JS, Hargrove J, et al. Evaluating the BED capture enzyme immunoassay to estimate HIV incidence among adults in three countries in Sub-Saharan Africa[J]. AIDS Res Hum Retroviruses, 2010,26(10):1051-1061. [16]Laeyendecker O, Brookmeyer R, Oliver AE, et al. Factors associated with incorrect identification of recent HIV infection using the BED capture immunoassay[J].AIDS Res Hum Retroviruses, 2012,28(8):816-822. [17]McWalter TA, Welte A. A comparison of biomarker based incidence estimators[J].PLoS One,2009,4(10):e7368. [18]Brookmeyer R. Should biomarker estimates of HIV incidence be adjusted[J].AIDS, 2009,23(4):485-491. [19]Brookmeyer R. Measuring the HIV/AIDS epidemic: approaches and challenges[J].Epidemiol Rev,2010,32(1):26-37. [20]McNicholl JM, McDougal JS, Wasinrapee P, et al. Assessment of BED HIV-1 incidence assay in seroconverter cohorts: effect of individuals with long-term infection and importance of stable incidence[J]. PLoS One,2011,6(3):e14748. [21]Busch MP, Pilcher CD, Mastro TD,et al.Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation[J].AIDS,2010,24(18):2763-2771. [22]Brookmeyer R, Konikoff J, Laeyendecker O, et al. Estimation of HIV incidence using multiple biomarkers[J]. Am J Epidemiol,2013,177(3):264-272.
2013, Vol. 1 
